Cancer Treatment Reviews
Volume 31, Issue 8 , Pages 591-602 , December 2005

Bortezomib, a novel proteasome inhibitor, in the treatment of hematologic malignancies

  • Graham Jackson

      Affiliations

    • Department of Haematology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle Upon Tyne NE1 4LP, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 191 2336161.
    • ,
  • Hermann Einsele

      Affiliations

    • Department of Haematology and Oncology, Julius-Maximilians-University of Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
    • ,
  • Phillippe Moreau

      Affiliations

    • Department of Clinical Hematology, University Hospital, Nantes, France
    • ,
  • Jesus San Miguel

      Affiliations

    • Department of Hematology, University Hospital of Salamanca, Paso de San Vicente 52-182, 37007 Salamanca, Spain

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(05)00199-4

doi: 10.1016/j.ctrv.2005.10.001

Cancer Treatment Reviews
Volume 31, Issue 8 , Pages 591-602 , December 2005

Article Tools

* Image Usage & Resolution